Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited - pharma in Bangalore North, Karnataka, India. FY 2026 financials and compliance.
CIN U73100KA2002PTC031038 Incorporated 24 September 2002 ROC Bangalore HQ Bangalore North, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹64.26 Cr
▼ 8.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹2.42 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
24 yrs
Est. 2002
Employees · EPFO
219
Latest available

About Fortrea Clinical Development Private Limited

Data last updated: 05 January 2026

Fortrea Clinical Development Private Limited is a private limited company based in Bangalore North, Karnataka, India, a subsidiary of Chiltern International Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 24 September 2002, the company has been in operation for over 24 years.

Registered with ROC Bangalore under CIN U73100KA2002PTC031038.

Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹2.42 Lakh. Formerly known as Omnicare Clinical Research India Private Limited and Covance Clinical Development Private Limited. It is led by directors David Howard Cooper and Rishi Raj Sharma.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Bangalore North, Karnataka.

As per the financials filed for FY 2025, the company reported a revenue of ₹64.26 Cr, a decline of 8% compared to the previous year.

The company has a workforce of approximately 219 employees as per the latest available data. It operates as a subsidiary of Chiltern International Limited.

The company is associated with 1 brand - Covance.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website drugdevelopment.labcorp.com.

Company Details of Fortrea Clinical Development Private Limited
CIN U73100KA2002PTC031038
Registration Number 031038
Incorporation Date 24 September 2002
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Chiltern International Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Sattva Knowledge Court 2Nd Floor Wing B Plot No. 9 Katha No. 299 Sy. No. 77, Doddenakkundi Phase I Industrial Area Whitefield Road, Bangalore North, Karnataka, India – 560048
  • Industry
    Pharma, Pharma Contract R&D
Company report
Fortrea Clinical Development Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Fortrea Clinical Development Private Limited report

Financials, compliance, directors, charges, ownership and filings for Fortrea Clinical Development Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited has undergone 5 name changes throughout its history. The current legal name is Fortrea Clinical Development Private Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Fortrea Clinical Development Private Limited Current
Omnicare Clinical Research India Private Limited Previous
Covance Clinical Development Private Limited Previous
Labcorp Clinical Development Private Limited Previous
Theorem Clinical Research India Private Limited Previous
Chiltern Clinical Research India Private Limited Previous

Associated Brands with Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited operates one associated brand: Covance. These brands represent Fortrea Clinical Development Private Limited's diversified market presence and brand portfolio.

Brand Description Website
CRO offering comprehensive drug development solutions from drug discovery to life cycle management covance.com

Competitors & Alternatives of Fortrea Clinical Development Private Limited

Brands and companies operating in the same space as Fortrea Clinical Development Private Limited include LabCorp, Charles River Laboratories, Cytel and 7 more.

Competitor Description Location Founded
LabCorp LabCorp Provider of laboratory tests for physicians Burlington, United States, United States 1969
Charles River Laboratories Charles River Laboratories Provider of drug discovery and preclinical development services Wilmington, United States, United States 1947
Cytel Cytel Data analysis and statistical solutions are provided for life sciences. Cambridge, United States, United States 1987
Precision Medicine Group Precision Medicine Group Provider of clinical research, development, and commercialization services for life sciences Bethesda, United States, United States 2012
Precision for Medicine Precision for Medicine Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices Bethesda, United States, United States 2013
Tenpoint Therapeutics Tenpoint Therapeutics Engineered cell-based therapeutics are developed to restore vision. Cambridge, United Kingdom, United Kingdom 2020
Taimei Technology Taimei Technology A digital intelligence platform is focused on life sciences activities. Pleasanton, United States, United States 2013
Frontage Laboratories Frontage Laboratories Early drug development services are provided for pharma firms. Exton, United States, United States 2001
Scantox Scantox Laboratory focused on providing pharmacology, toxicology, and histopathology services Lille Skensved, Denmark, Denmark 1977
Canopy Biosciences Canopy Biosciences Cell line engineering services are offered via CRISPR-Cas9 technology. St. Louis, United States, United States 2016

Business Activity of Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Fortrea Clinical Development Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited is audited by Vasan & Sampath LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Vasan & Sampath LLP Locked Locked Locked
Premium access

Complete auditor history for Fortrea Clinical Development Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited is currently managed by 2 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
David Howard Cooper Director 30 Jun 2023 3 Years 1 Months Current
Rishi Raj Sharma Director 11 Sep 2023 2 Years 11 Months Current

Financials of Fortrea Clinical Development Private Limited FY 2025 filings available

Fortrea Clinical Development Private Limited reported revenue of ₹64.26 Cr (down 8.00% YoY) for FY 2025.

Revenue · FY 2025
₹64.26 Cr ▼ 8.00%
Premium access

Ten-year financial statements for Fortrea Clinical Development Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Fortrea Clinical Development Private Limited

Premium access

Shareholding and ownership data for Fortrea Clinical Development Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited has a workforce of 219 employees as of Mar 24, 2024.

Employee count
219
Active EPFO establishments
1
Employee growth
-19.49%
Premium access

Employee and EPFO history for Fortrea Clinical Development Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Fortrea Clinical Development Private Limited

Premium access

GST registrations and filing compliance for Fortrea Clinical Development Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Fortrea Clinical Development Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Fortrea Clinical Development Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Fortrea Clinical Development Private Limited

Premium access

MSME payment history for Fortrea Clinical Development Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Fortrea Clinical Development Private Limited

Premium access

Corporate group structure for Fortrea Clinical Development Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Fortrea Clinical Development Private Limited

Premium access

MCA filings and documents for Fortrea Clinical Development Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Fortrea Clinical Development Private Limited

Activity
30 Sep 2025
Fortrea Clinical Development Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Fortrea Clinical Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Directors
11 Sep 2023
Rishi Raj Sharma was appointed as a Director on 11 Sep 2023 & has been associated with this company since 2 years 11 months.
Directors
30 Jun 2023
David Howard Cooper was appointed as a Director on 30 Jun 2023 & has been associated with this company since 3 years 1 month.
Activity
24 Sep 2002
Fortrea Clinical Development Private Limited was registered on 24 Sep 2002 with Roc Bangalore & aged 23 years 10 months as per MCA records.

Frequently Asked Questions about Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited is an active private limited company in the pharma sector based in Bangalore North, Karnataka, India. It was incorporated on 24 September 2002 (24+ years old) and is registered under CIN U73100KA2002PTC031038. The company has 219 employees.

Fortrea Clinical Development Private Limited reported revenue of ₹64.26 Cr for FY 2025 (down 8.00% YoY).

The current directors of Fortrea Clinical Development Private Limited are:

The primary industry of Fortrea Clinical Development Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Fortrea Clinical Development Private Limited can be reached at the registered office: Sattva Knowledge Court 2Nd Floor Wing B Plot No. 9 Katha No. 299 Sy. No. 77, Doddenakkundi Phase I Industrial Area Whitefield Road, Bangalore North, Karnataka, India – 560048, or through the website drugdevelopment.labcorp.com.

The authorised capital is ₹50 Lakh, and the paid-up capital is ₹2.42 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available